Author Archives: Scalper1

Pfizer Acquiring Anacor For Potential Blockbuster Eczema Drug

Big pharma Pfizer ( PFE ) said Monday that it’s acquiring small biopharma Anacor Pharmaceuticals ( ANAC ) for $4.5 billion in cash, sending the latter’s stock up more than 50% in early Monday trading. Pfizer agreed to pay $99.26 a share for Anacor, a 55% premium over Friday’s closing price. The total transaction value is $5.2 billion, assuming the conversion of Anacor’s outstanding convertible notes, Pfizer said. Anacor’s sole commercial product is a toenail-fungus ointment called Kerydin, distributed by Novartis ( NVS ), but Pfizer’s press release on the merger played up Anacor’s eczema treatment crisaborole, which is under FDA review due for completion by Jan. 7. “We believe the acquisition of Anacor represents an attractive opportunity to address a significant unmet medical need for a large patient population with mild-to-moderate atopic dermatitis, which currently has few safe topical treatments available,” said Albert Bourla, head of Pfizer’s innovative businesses, in the release. Pfizer estimates crisaborole could reach peak annual sales of $2 billion. The buyout adds another asset to Pfizer’s innovate drug business, which it is widely expected to separate from its established-products business sometime in the next few years. Pfizer has said that it will make a decision on whether to split by year’s end. Pfizer already has a significant presence in inflammation and immunology, including blockbuster rheumatoid arthritis treatments Enbrel (sold in partnership with Amgen ( AMGN )) and Xeljanz.  Regeneron Pharmaceuticals ( REGN ) recently reported strong late-stage data for its injectable drug dupilumab in atopic dermatitis, so while the market is currently underserved, it may soon become more competitive. Anacor stock was up 54.7% in opens trades  on the stock market today , near 99. Pfizer stock was down a fraction, near 33. Regeneron stock was up almost 3%.

Will Buffett Stand In Verizon’s Way, Snatching Up Yahoo?

Will Warren Buffett stand in the way of  Verizon Communications ( VZ ) snatching up Web portal Yahoo ( YHOO )? That scenario looms amid reports that Berkshire Hathawa y ( BRKB ) Chairman Buffett is backing a consortium  vying for Yahoo’s Internet assets. Quicken Loans founder Dan Gilbert is said to be pursuing Yahoo, with Buffett providing financial backing. Some former Yahoo executives have been advising Gilbert’s group  on a bid, tech news website Re/Code reported. Buffett’s Berkshire Hathaway made its biggest-ever acquisition in 2015, buying Precision Castparts, a maker of aerospace components, for $37 billion. However, Buffett has not been a big investor in tech companies, with his large stake in IBM ( IBM ) a notable exception. Berkshire, however, just disclosed that it’s taken a nearly $900 million investment in Apple ( AAPL ) shares. “I’m an enormous admirer of Dan and what he has accomplished in Quicken Loans‎,” Buffett told CNBC . “Yahoo is not the type of thing I’d ever be an equity partner in. I don’t know the business and wouldn’t know how to evaluate it, but if Dan needed financing, with proper terms and protections, we would be a possible financing help.” Others in the hunt for Yahoo include big private equity firm TPG Capital and a group comprised of investment firms Bain Capital and Vista Equity Partners. Telecom and wireless services giant Verizon has been viewed as the front-runner for acquiring all or part of Yahoo. Verizon, which bought AOL in 2015 for $4.4 billion, aims to morph into a digital media company that garners more advertising revenue, as wireless data competition mounts. Yahoo recently added four new independent directors to its board under pressure by activist investor Starboard Value. While Yahoo CEO Marissa Mayer is in talks with possible buyers, a second round of bidding for Yahoo may not wind up until early June, according to various reports.